{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:21:19Z","timestamp":1772918479688,"version":"3.50.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1065,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Psychiatric disorders and medications may affect the cognitive performance of patients with cirrhosis and complicate the diagnosis and prediction of hepatic encephalopathy (HE). The aim of this study was to study the association of psychoactive medications with cognitive performance and their effects on the ability of tests to predict HE development in patients with cirrhosis referred for transplant evaluation. Cirrhosis details, psychiatric disorders, psychoactive medications, and any history of prior HE were recorded for patients with cirrhosis at 2 transplant centers. Patients were followed until the development of HE. Five cognitive tests\u2014number connection test A (NCT-A), number connection test B, the digit symbol test (DST), the block design test, and the inhibitory control test (ICT)\u2013were administered. A high lure score and a low ICT target score indicated poor performance. The cognitive performances of patients with psychiatric disorders\/medications and patients without them were compared. A proportional hazards model was created with the time to HE as the outcome, and it was based on demographics, psychoactive medications, cirrhosis details, and individual cognitive scores. Patients with prior HE and patients without prior HE were then studied separately. One hundred fifty-five patients with a mean age of 57.5 \u00b1 6.2 years and a mean Model for End-Stage Liver Disease (MELD) score of 15.1 \u00b1 6.2 were included [prior HE, 48%; diabetes, 34%; selective serotonin reuptake inhibitors (SSRIs), 32%; opioids, 19%; and antipsychotics, 10%]. Prior HE and antipsychotics (but not opioids or diabetes) were associated with worse cognition. SSRI users had better NCT-A and DST performance. One hundred forty-eight patients were followed for a median of 182.5 days; 58 developed HE at a median of 99 days after inclusion. In the entire group, the model showed that prior HE (hazard ratio = 4.13), the MELD score (hazard ratio = 1.07), and a high lure score (hazard ratio = 1.04) decreased the time to HE, whereas the use of SSRIs (hazard ratio = 0.42), a high target score (hazard ratio = 0.95), and a high sodium level (hazard ratio = 0.89) increased the time to HE. For patients without prior HE, the MELD score (hazard ratio = 1.25) and lures (hazard ratio = 1.09) predicted the time to HE. Lures (hazard ratio = 1.03), targets (hazard ratio = 0.96), and sodium (hazard ratio = 0.87) were associated with the time to HE in patients with prior HE. In conclusion, cognitive tests (particularly the ICT) remain valid predictors of HE in the face of psychiatric diseases and medications. SSRI use is associated with better cognitive performance and a reduced likelihood of developing HE. Liver Transpl 18:1179\u20131187, 2012. \u00a9 2012 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.23484","type":"journal-article","created":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T20:46:23Z","timestamp":1338842783000},"page":"1179-1187","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: A prospective study"],"prefix":"10.1097","volume":"18","author":[{"given":"Jasmohan S.","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leroy R.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas M.","family":"Heuman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd R.","family":"Stravitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velimir","family":"Luketic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Chong S.","family":"Gilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20250124","doi-asserted-by":"crossref","first-page":"20142021","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy.","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"R2-9-20250124","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning.","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology"},{"key":"R3-9-20250124","doi-asserted-by":"crossref","first-page":"16461653","DOI":"10.1038\/ajg.2011.157","article-title":"The multidimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.","volume":"106","author":"Bajaj","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"pt 9","key":"R5-9-20250124","first-page":"24782492","article-title":"The clinical diagnosis of earlyonset dementias: diagnostic accuracy and clinicopathological relationships.","volume":"134","author":"Snowden","year":"2011","journal-title":"Brain"},{"key":"R6-9-20250124","first-page":"157166","article-title":"Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment.","volume":"30","author":"GrauOlivares","year":"2010","journal-title":"Cerebrovasc Dis"},{"key":"R7-9-20250124","doi-asserted-by":"crossref","first-page":"332342","DOI":"10.1038\/nrneurol.2011.61","article-title":"Risk factors for and management of cognitive dysfunction in multiple sclerosis.","volume":"7","author":"Benedict","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R8-9-20250124","first-page":"7388","article-title":"Natural history of recovery from brain injury after prolonged disorders of consciousness: outcome of patients admitted to inpatient rehabilitation with 1-4 year followup.","volume":"177","author":"Katz","year":"2009","journal-title":"Prog Brain Res"},{"key":"R9-9-20250124","doi-asserted-by":"crossref","first-page":"174181","DOI":"10.1111\/j.1440-1819.2006.01483.x","article-title":"Cognitive impairment in people diagnosed with endstage liver disease evaluated for liver transplantation.","volume":"60","author":"Sorrell","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"R10-9-20250124","doi-asserted-by":"crossref","first-page":"10301040","DOI":"10.1016\/j.jhep.2010.11.015","article-title":"New assessment of hepatic encephalopathy.","volume":"54","author":"Cordoba","year":"2011","journal-title":"J Hepatol"},{"key":"R12-9-20250124","doi-asserted-by":"crossref","first-page":"716721","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathydefinition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"R14-9-20250124","doi-asserted-by":"crossref","first-page":"11751183","DOI":"10.1002\/hep.23128","article-title":"Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"R15-9-20250124","doi-asserted-by":"crossref","first-page":"476482","DOI":"10.1038\/ajg.2010.413","article-title":"Minimal hepatic encephalopathy is associated with falls.","volume":"106","author":"Roman","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R16-9-20250124","doi-asserted-by":"crossref","first-page":"23812390","DOI":"10.1007\/s10620-010-1249-7","article-title":"Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver.","volume":"55","author":"Dhiman","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R17-9-20250124","doi-asserted-by":"crossref","first-page":"16621667","DOI":"10.1002\/hep.510290619","article-title":"Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.","volume":"29","author":"Amodio","year":"1999","journal-title":"Hepatology"},{"key":"R18-9-20250124","doi-asserted-by":"crossref","first-page":"12871295","DOI":"10.1111\/j.1600-6143.2011.03496.x","article-title":"Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts longterm survival.","volume":"11","author":"DiMartini","year":"2011","journal-title":"Am J Transplant"},{"key":"R19-9-20250124","doi-asserted-by":"crossref","first-page":"949981","DOI":"10.1016\/j.ccc.2008.05.001","article-title":"Psychiatric aspects of organ transplantation in critical care.","volume":"24","author":"DiMartini","year":"2008","journal-title":"Crit Care Clin"},{"key":"R20-9-20250124","doi-asserted-by":"crossref","first-page":"116126","DOI":"10.1007\/s11916-003-0021-5","article-title":"Cognitive impairment in patients with chronic pain: the significance of stress.","volume":"7","author":"Hart","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"R21-9-20250124","doi-asserted-by":"crossref","first-page":"267284","DOI":"10.2165\/11530230-000000000-00000","article-title":"Defining and measuring functional recovery from depression.","volume":"24","author":"Greer","year":"2010","journal-title":"CNS Drugs"},{"key":"R22-9-20250124","doi-asserted-by":"crossref","first-page":"10801088","DOI":"10.1002\/gps.2647","article-title":"Anxiety disorders, depressive episodes and cognitive impairment no dementia in communitydwelling older men and women.","volume":"26","author":"Potvin","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"R23-9-20250124","doi-asserted-by":"crossref","first-page":"211218","DOI":"10.1192\/bjp.bp.110.090217","article-title":"Changes in neuropsychological functioning following treatment for latelife generalised anxiety disorder.","volume":"199","author":"Butters","year":"2011","journal-title":"Br J Psychiatry"},{"key":"R25-9-20250124","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1016\/0006-8993(92)91080-X","article-title":"Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil.","volume":"590","author":"Nakata","year":"1992","journal-title":"Brain Res"},{"key":"R26-9-20250124","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/sj.mp.4000954","article-title":"Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats.","volume":"6","author":"Lee","year":"2001","journal-title":"Mol Psychiatry"},{"key":"R28-9-20250124","doi-asserted-by":"crossref","first-page":"831839","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimers disease: outcomes from CATIEAD.","volume":"168","author":"Vigen","year":"2011","journal-title":"Am J Psychiatry"},{"key":"R29-9-20250124","doi-asserted-by":"crossref","first-page":"985987","DOI":"10.1002\/hep.25583","article-title":"Attention: minimal hepatic encephalopathy and road accidents.","volume":"55","author":"Amodio","year":"2012","journal-title":"Hepatology"},{"key":"R30-9-20250124","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1212\/WNL.43.1_Part_1.13","article-title":"Education and the prevalence of dementia and Alzheimers disease.","volume":"43","author":"Katzman","year":"1993","journal-title":"Neurology"},{"key":"R31-9-20250124","doi-asserted-by":"crossref","first-page":"273295","DOI":"10.1037\/0894-4105.7.3.273","article-title":"Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory.","volume":"7","author":"Satz","year":"1993","journal-title":"Neuropsychology"},{"key":"R32-9-20250124","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1192\/bjp.169.1.86","article-title":"Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimers disease.","volume":"169","author":"Graves","year":"1996","journal-title":"Br J Psychiatry"},{"key":"R33-9-20250124","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1212\/WNL.49.1.30","article-title":"An association between head circumference and Alzheimers disease in a populationbased study of aging and dementia.","volume":"49","author":"Schofield","year":"1997","journal-title":"Neurology"},{"key":"R34-9-20250124","doi-asserted-by":"crossref","first-page":"13821389","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with timedependent analysis.","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R35-9-20250124","doi-asserted-by":"crossref","first-page":"541552","DOI":"10.1016\/j.neuroimage.2004.01.038","article-title":"Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study.","volume":"22","author":"Zafiris","year":"2004","journal-title":"Neuroimage"},{"key":"R36-9-20250124","doi-asserted-by":"crossref","first-page":"768773","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy.","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J Hepatol"},{"key":"R37-9-20250124","doi-asserted-by":"crossref","first-page":"596604","DOI":"10.1002\/hep.22032","article-title":"Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy.","volume":"47","author":"Bajaj","year":"2008","journal-title":"Hepatology"},{"key":"R38-9-20250124","doi-asserted-by":"crossref","first-page":"510518","DOI":"10.1053\/j.gastro.2010.04.057","article-title":"Improving the inhibitory control task to detect minimal hepatic encephalopathy.","volume":"139","author":"Amodio","year":"2010","journal-title":"Gastroenterology"},{"key":"R39-9-20250124","doi-asserted-by":"crossref","first-page":"121123","DOI":"10.1002\/lt.21638","article-title":"The importance of hepatic encephalopathy: pretransplant and posttransplant.","volume":"15","author":"DiMartini","year":"2009","journal-title":"Liver Transpl"},{"key":"R40-9-20250124","first-page":"3846","article-title":"Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.","volume":"17","author":"GarciaMartinez","year":"2011","journal-title":"Liver Transpl"},{"key":"R41-9-20250124","doi-asserted-by":"crossref","first-page":"23322340","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"key":"R42-9-20250124","doi-asserted-by":"crossref","first-page":"181183","DOI":"10.1016\/j.cgh.2010.10.002","article-title":"Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy.","volume":"9","author":"Riggio","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R43-9-20250124","doi-asserted-by":"crossref","first-page":"13661371","DOI":"10.1002\/lt.21129","article-title":"Hepatic encephalopathy as a predictor of survival in patients with endstage liver disease.","volume":"13","author":"Stewart","year":"2007","journal-title":"Liver Transpl"},{"key":"R45-9-20250124","doi-asserted-by":"crossref","first-page":"833834","DOI":"10.1002\/hep.21515","article-title":"Testing for minimal hepatic encephalopathy in the United States: an AASLD survey.","volume":"45","author":"Bajaj","year":"2007","journal-title":"Hepatology"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.23484","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201210000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:22:06Z","timestamp":1737739326000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201210000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.23484","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}